Teikoku Pharma USA
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Teikoku Pharma USA sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Teikoku Pharma USA: 5 sponsored US clinical trials, 1 recruiting.
Teikoku Pharma USA sponsors 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Agitation, with 1 trials.
Upper-quartile sponsor footprint
Teikoku Pharma USA sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
NCT06052254
Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following Abdominoplasty
NCT05412992
Study in Elderly Alzheimer's Patients to Assess Skin Tolerability, Irritation With 3, 7-Day Applications of DTP-System
NCT00916383
Flurbiprofen Tape for Treatment of Chronic Low Back Pain
NCT00759330
Study of a New Dressing for Use With Topical Medications
NCT00234728
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 4 |
Therapeutic Areas
What is open in the Teikoku Pharma USA pipeline
1 recruiting of 5 indexed (20% open); 3 completed (60%).
Phase mix: 0 late (III/IV) vs 4 early (I/II) (early-phase heavy).
Top condition: Agitation (1 trial), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Teikoku Pharma USA: open-pipeline peers nationwide
Peers matched on 5 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
Teikoku Pharma USA sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
- Amazentis · 20% recruiting · 5 trials
Related
What to do with this Teikoku Pharma USA page
5 registered trials is a research-attention snapshot, not an endorsement of Teikoku Pharma USA or any single study.
- 1 of Teikoku Pharma USA's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Agitation is the condition Teikoku Pharma USA studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Agitation trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Teikoku Pharma USA pipeline card: 5 registered trials from official public datasets.Report a data error.